P-Rex1 and P-Rex2 RacGEFs and cancer
Related Experiment Video
Updated: Feb 26, 2026

Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites
Published on: June 2, 2023
Nuthasuda Srijakotre1, Joey Man1, Lisa M Ooms1
1Cancer Program, Monash Biomedicine Discovery Institute, and Department of Biochemistry and Molecular Biology, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia.
Abstract:
Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger (P-Rex) proteins are RacGEFs that are synergistically activated by phosphatidylinositol 3,4,5-trisphosphate and Gβγ subunits of G-protein-coupled receptors. P-Rex1 and P-Rex2 share similar amino acid sequence homology, domain structure, and catalytic function. Recent evidence suggests that both P-Rex proteins may play oncogenic roles in human cancers. P-Rex1 and P-Rex2 are altered predominantly via overexpression and mutation, respectively, in various cancer types, including breast cancer, prostate cancer, and melanoma. This review compares the similarities and differences between P-Rex1 and P-Rex2 functions in human cancers in terms of cellular effects and signalling mechanisms. Emerging clinical data predict that changes in expression or mutation of P-Rex1 and P-Rex2 may lead to changes in tumour outcome, particularly in breast cancer and melanoma.
Insights
Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchangers (P-Rex1 and P-Rex2) show oncogenic roles in cancers. Their altered expression and mutation impact tumor outcomes, especially in breast cancer and melanoma.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- P-Rex proteins are RacGEFs activated by phosphatidylinositol 3,4,5-trisphosphate and Gβγ subunits.
- P-Rex1 and P-Rex2 share structural and functional similarities.
- Both P-Rex proteins are implicated in human cancer development.
Purpose of the Study:
- To compare the functions of P-Rex1 and P-Rex2 in human cancers.
- To elucidate their cellular effects and signaling mechanisms in oncogenesis.
- To review emerging clinical data on their impact on tumor outcomes.
Main Methods:
- Comparative analysis of P-Rex1 and P-Rex2 functions.
- Review of existing literature on P-Rex proteins in cancer.
- Examination of cellular effects and signaling pathways.
Main Results:
- P-Rex1 and P-Rex2 exhibit oncogenic roles, with P-Rex1 often overexpressed and P-Rex2 mutated in cancers.
- Alterations in P-Rex1 and P-Rex2 are observed in breast cancer, prostate cancer, and melanoma.
- Functional similarities and differences between P-Rex1 and P-Rex2 in cancer contexts were detailed.
Conclusions:
- P-Rex1 and P-Rex2 are significant players in human oncogenesis.
- Changes in P-Rex1 and P-Rex2 expression or mutation are linked to tumor progression.
- Further research into P-Rex proteins may offer new therapeutic strategies for cancer.
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation

